Amgen Deutschland is a leading independent biotechnology company that specializes in innovative therapies. With a strong focus on science and research, they have established themselves as experts in the field of biotechnology. Their mission is to improve the lives of patients by developing and manufacturing biologic medicines.

Amgen Deutschland offers a wide range of innovative therapies in various therapeutic areas, including oncology, hematology, cardiology, and chronic inflammatory diseases. They are constantly exploring new approaches in cancer therapy and developing cutting-edge BiTE® molecules. In addition to their commitment to scientific advancement, Amgen Deutschland is actively engaged in networks and initiatives dedicated to promoting bone health and nephrology.

Furthermore, Amgen Deutschland provides valuable resources for healthcare professionals through their portal for specialized information and engagement programs like Amgen Biotech Experience and Amgen Scholars Europe Program. With a strong emphasis on ethics, compliance, and transparency, Amgen Deutschland is dedicated to providing high-quality biotechnological treatments that make a real difference in the lives of patients